Home | Business News | CBJ Newsmakers | Ceapro Inc. Receives Research License from Health Canada Controlled Substances and Cannabis Branch Ceapro Inc. Receives Research License from Health Canada Controlled Substances and Cannabis Branch EDMONTON, Alberta, Feb. 14, 2020 (GLOBE NEWSWIRE) — Ceapro Inc. (TSX-V: CZO; OTCQX: CBJ Newsmakers RecommendedMillrock Receives Cash and Share Payments; Resolution Minerals Earns 30% Interest in Millrock’s 64North Gold Project, AlaskaThe Flowr Corporation Wins Brand of the Year at ADCANN & Continues to Win Additional AwardsKinross announces additional investment in Wolfden Resources Corporation
